Filing search / Centessa Pharmaceuticals plc / "Hedging"

424B5

CNTA Centessa Pharmaceuticals plc

13 Sep 24

Prospectus supplement for primary offering

4:02pm

sales and trading, commercial and investment banking, advisory, investment S-20 management, investment research, principal investment, hedging … ; dealers or traders in securities who use a mark-to-market method of tax accounting; persons holding ADSs as part of a hedging transaction, “straddle

8-K

EX-1.1

CNTA Centessa Pharmaceuticals plc

13 Sep 24

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

4:00pm

. The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions designed

424B5

CNTA Centessa Pharmaceuticals plc

11 Sep 24

Prospectus supplement for primary offering

4:40pm

, commercial and investment banking, advisory, investment S-20 management, investment research, principal investment, hedging, market making, brokerage … in securities who use a mark-to-market method of tax accounting; persons holding ADSs as part of a hedging transaction, “straddle,” wash sale, conversion

S-3ASR

CNTA Centessa Pharmaceuticals plc

11 Sep 24

Automatic shelf registration

4:01pm

) of the Securities Act. We may enter into derivative or hedging transactions with third parties or sell securities not covered by this prospectus to third

PRE 14A

dfh8wxnw caub1

26 Apr 24

Preliminary proxy

4:36pm

424B5

hs2tyrirkbpe

24 Apr 24

Prospectus supplement for primary offering

8:53pm

424B5

zz4xl lx7

23 Apr 24

Prospectus supplement for primary offering

5:16pm

S-3

rm3 uyrxrex48w4x

1 Jul 22

Shelf registration

4:06pm

DEF 14A

uxhal4n63 cn

23 May 22

Definitive proxy

8:00am

S-1/A

EX-10.27

3xz6ysvo1 gywgynaz4v

12 May 21

IPO registration (amended)

5:19pm

S-1/A

EX-10.28

wnzwk6ldqohgmd89cc

12 May 21

IPO registration (amended)

5:19pm